Post-influenza pneumonia caused by the USA300 community-associated methicillin-resistant Staphylococcus aureus in

Kyung Mok Sohn1, Doo Ryeon Chung, Jin Yang Baek

  • 1Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

The USA300 community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain caused pneumonia in Korea. This marks the first reported case of USA300 pneumonia following pandemic influenza A (H1N1).

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • The USA300 clone is a successful community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain prevalent in North America.
  • PVL-negative ST72-CA-MRSA has been predominant in Korea, with limited reports of USA300 infections.

Observation:

  • A 50-year-old man in Korea developed pneumonia after influenza A (H1N1) infection.
  • The patient required ventilator support due to respiratory failure.

Findings:

  • Sputum and endotracheal aspirate cultures identified MRSA.
  • Molecular typing confirmed the isolate as PVL-positive, ST 8-MRSA-SCCmec type IV, matching the USA300 strain.
  • Pulsed-field gel electrophoresis (PFGE) patterns confirmed the isolate's identity as USA300.

Implications:

  • This case highlights the emergence of the USA300 CA-MRSA strain in Korea, causing pneumonia post-influenza A (H1N1).
  • It underscores the need for enhanced surveillance of CA-MRSA infections, particularly in the context of viral respiratory infections.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...